Redox Raises $45m Series D

Redox closed a $45m Series D led by Adams Street Partners with participation from Avenir, Battery Ventures, .406 Ventures, and RRE Ventures. Huge congratulations to the whole Redox team!

Read the press release here: https://www.businesswire.com/news/home/20210224005357/en/Redox-Raises-45M-in-Series-D-to-Drive-the-Adoption-of-Technology-in-Healthcare

Sleep Industry Leads at Telehealth Adoption

As healthcare increasingly relies on telehealth, one industry has lead the charge: sleep. EnsoData has been a critical piece of this shift as their technology allows for remote sleep studies and study analyses.

Read more here: https://www.prweb.com/releases/sleep_industry_leads_the_charge_in_telehealth_adoption_new_data_highlights_room_for_growth/prweb17654068.htm

Health iPASS is acquired by Sphere

Sphere, a leading provider of end-to-end integrated payments and security software, acquired Health iPASS on December 13, 2020. Congratulations to the Health iPASS and Sphere teams!

Read more here: https://www.prweb.com/releases/sphere_announces_acquisition_of_patient_engagement_and_revenue_cycle_management_platform_health_ipass/prweb17620946.htm

Medable CEO Dr. Michelle Longmire on Using Tech to Improve Clinical Trial Access

Medable’s CEO, Dr. Michelle Longmire, recently spoke to Bloomberg about how technology can be leveraged to improve access to clinical trials. Medable was founded to help health systems, insurance providers, pharma companies, device manufacturers, and academia quickly deploy clinical trials. The Company’s platform also helps customers collect data that then drives healthcare delivery and provides context about each patient’s clinical trial results.

Listen to the interview here: https://www.bloomberg.com/news/audio/2020-11-25/using-tech-to-improve-access-to-covid-19-trials-podcast

EnsoData Co-Founders Nominated to Forbes 30 Under 30 Healthcare List

EnsoData’s co-founding team, Chris Fernandez, Nick Glattard, and Sam Rusk, have been nominated to the 2021 Forbes 30 Under 30 Healthcare List. They founded the Company in 2015 to tackle the nearly 20 million US citizens who have undiagnosed sleep apnea. EnsoData’s technology is able to automate the traditionally manual, time-intensive scoring of sleep studies, delivering more accurate results in a matter of minutes. Congratulations to EnsoData and the team!

See the full article here: https://www.forbes.com/profile/ensodata/?sh=1c73e3c8194c